Almaject is focused on the development, acquisition, and commercialization of injectable generic pharmaceutical products. The current portfolio of injectables covers a broad range of therapeutic areas. Our commercial, business development, and R&D teams are creating new opportunities to expand our portfolio into complex molecules. Almaject, Inc. is a US subsidiary of Alvogen.